Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4595287 | 1.00 | GAA (0.47) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL4595179 | 1.00 | GAA (0.47) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL4595934 | 0.94 | PTGS2 (0.47) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL4595680 | 0.94 | PTGS2 (0.47) | GAAALDH1A1TSHRLMNAKMT2A | |
| Propionic Acid SCHEMBL29043770 | 0.90 | GAA (0.46) | GAAALDH1A1TSHRLMNAKMT2A | |
| Propionic Acid SCHEMBL31618954 | 0.90 | GAA (0.46) | GAAALDH1A1TSHRLMNAKMT2A | |
| Propionic Acid SCHEMBL31618955 | 0.90 | GAA (0.46) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL9472453 | 0.88 | GAA (0.41) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL18193749 | 0.88 | ALDH1A1 (0.57) | GAAALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL3762751 | 0.88 | ALDH1A1 (0.57) | GAAALDH1A1TSHRLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010009275-A1 | METHODS OF TREATING INFLAMMATION | INTEGRITAS PHARMA, INC (US) | 2010-01-21 | — | — | WO | claimed |
| EP-1416926-A4 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | SMITH JEFFREY B (US) | 2009-03-04 | — | — | EP | claimed |
| US-7462369-B2 | Anti-viral compositions and methods of making and using the anti-viral compositions | Smith, Jeffrey B. (US) | 2008-12-09 | — | — | US | claimed |
| US-20080274209-A1 | METHODS OF TREATING INFLAMMATION | INTEGRITAS PHARMA, INC. | 2008-11-06 | — | — | US | claimed |
| CN-1305467-C | Zinc-containing compositions for antiviral use | SMITH J B (US) | 2007-03-21 | — | — | CN | claimed |
| US-6855341-B2 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2005-02-15 | — | — | US | claimed |
| US-20050003020-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2005-01-06 | — | — | US | claimed |
| CN-1533272-A | Zinc-containing compositions for antiviral use | J��B��ʷ��˹ | 2004-09-29 | — | — | CN | claimed |
| EP-1416926-A2 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | Smith, Jeffrey B. (US) | 2004-05-12 | — | — | EP | claimed |
| US-20040086575-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | SMITH JEFFREY B (US) | 2004-05-06 | — | — | US | claimed |
| US-6730329-B1 | TREATING LESIONOUS SYMPTOMS TOPICALLY WITH ACTIVE MATERIAL SALT AND ANTIOXIDANT | SMITH JEFFREY B (US) | 2004-05-04 | — | — | US | claimed |
| WO-2002098339-A2 | ZINC CONTAINING COMPOSITIONS FOR ANTI-VIRAL USE | SMITH JEFFREY B (US) | 2002-12-12 | — | — | WO | claimed |
| US-6475526-B1 | Zinc containing compositions for anti-viral use | SMITH JEFFREY B (US) | 2002-11-05 | — | — | US | claimed |
| EP-3844212-B1 | EXTRUDABLE POLY(PROPYLENE) COATING COMPOSITIONS | IBM (US) | 2022-10-12 | — | — | EP | disclosed |
| US-10745579-B2 | Extrudable poly(propylene) compositions | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-08-18 | — | — | US | disclosed |
| US-20200071557-A1 | EXTRUDABLE POLY(PROPYLENE) COMPOSITIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2020-03-05 | — | — | US | disclosed |
| US-4584146-A | Tetrakis(2,6-di-t-butyl-4-substituted phenyl)4,4'-bisphenyl diphosphites | THE B. F. GOODRICH COMPANY (US) | 1986-04-22 | — | — | US | disclosed |
| US-4552682-A | Peroxide composition containing phenolic antioxidant | PPG INDUSTRIES, INC. (US) | 1985-11-12 | — | — | US | disclosed |
| US-4439570-A | BUTADIENE RUBBERS, THIORGANO PHOSPHINE | EUTECO IMPIANTI S.P.A. (IT) | 1984-03-27 | — | — | US | disclosed |
| EP-0078244-A1 | Phenolic antioxidant compositions for organic polymers | EUTECO IMPIANTI S.p.A. (IT) | 1983-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274209-A1 | METHODS OF TREATING INFLAMMATION | MPO, SOD1, MMP8 | GAA 289/4885ALDH1A1 1341/4885TSHR 4761/4885 |
| US-20040086575-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | ZC3HAV1, ZC3HAV1L, SOD3 | GAA 168/4885ALDH1A1 3146/4885TSHR 4875/4885 |
| US-20050003020-A1 | Anti-viral compositions and methods of making and using the anti-viral compositions | ZC3HAV1, ZC3HAV1L, SOD3 | GAA 168/4885ALDH1A1 3146/4885TSHR 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.